Research on the Brain Mechanism of taVNS in Regulating PD Motor Symptoms

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 11, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

September 30, 2024

Conditions
Parkinson Disease
Interventions
DEVICE

Transcutaneous auricular vagus nerve stimulation (active)

Transcutaneous auricular vagus nerve stimulation was conducted by transcutaneous electrical stimulation therapy instrument to the cymba conchae of left ear in the vicinity of the auricular branch vagus nerve. Stimulation parameters: frequency = 20 Hz; pulse width = 500 μs, twice a day, 30 minutes each time.

DEVICE

Transcutaneous auricular vagus nerve stimulation (sham)

In the sham stimulation group, the electrodes were fixed at the left earlobe with the same stimulus parameters. Stimulation parameters: frequency = 20 Hz; pulse width = 500 μs, twice a day, 30 minutes each time.

Trial Locations (1)

210029

RECRUITING

the First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER